Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,531 | -28,023 | -23,008 | -10,002 | -24,557 |
| Depreciation Amortization | 1,745 | 1,306 | 867 | 432 | 1,744 |
| Accounts receivable | N/A | -66 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -364 | -1,017 | -817 | 8 | 91 |
| Other Working Capital | -1,459 | -260 | 667 | 405 | 2,719 |
| Other Operating Activity | 7,646 | 3,637 | 3,713 | 1,955 | 1,278 |
| Operating Cash Flow | $-30,963 | $-24,423 | $-18,578 | $-7,202 | $-18,725 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 61,859 |
| PPE Investments | -1,304 | -1,220 | -882 | -255 | -362 |
| Investing Cash Flow | $-1,304 | $-1,220 | $-882 | $-255 | $61,497 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 10,250 | 10,000 | 10,000 | 10,000 | N/A |
| Common Stock Issued | 200 | 167 | 103 | 55 | 5 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -14 |
| Financing Cash Flow | $10,450 | $10,167 | $10,103 | $10,055 | $-9 |
| Exchange Rate Effect | -5,529 | -1,429 | -2,136 | -1,582 | -46 |
| Beginning Cash Position | 200,023 | 200,023 | 200,023 | 200,023 | 157,306 |
| End Cash Position | 172,677 | 183,118 | 188,530 | 201,039 | 200,023 |
| Net Cash Flow | $-27,346 | $-16,905 | $-11,493 | $1,016 | $42,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | -30,963 | -24,423 | -18,578 | -7,202 | -18,725 |
| Capital Expenditure | -1,304 | -1,220 | -882 | -255 | -362 |
| Free Cash Flow | -32,267 | -25,643 | -19,460 | -7,457 | -19,087 |